Task: Answer Verification
Input (English): Question: Does expression of Bcl-2 predict outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy?
Answer: High expression of Bcl-2 may be a useful prognostic factor in locally advanced NSCLC patients treated with cisplatin-based CCRT.
Output (English): yes